2 Oct 2026, 15:57
Company Administration—
OSXOSTEOPORE LIMITED
Announcement history available from 1 August 2025
Fromto
9 Sept 2026, 08:33
Company Update—
31 Aug 2026, 19:22
Financial ResultsMS
6 Aug 2026, 08:45
Company UpdateMS
3 Aug 2026, 18:25
Other—
3 Aug 2026, 08:35
Company Update—
31 July 2026, 09:01
Quarterly ReportsMS
23 July 2026, 18:52
Securities Administration—
14 July 2026, 08:43
Company Update—
7 July 2026, 08:34
Company Update—
2 July 2026, 08:24
Company Update—
30 June 2026, 08:52
Company Update—
29 June 2026, 08:26
Company Update—
26 June 2026, 08:17
Company Update—
24 June 2026, 08:52
Company Update—
23 June 2026, 09:02
Securities Administration—
23 June 2026, 08:57
Securities Administration—
23 June 2026, 08:51
Securities AdministrationMS
22 June 2026, 08:41
Company Update—
17 June 2026, 08:51
Company Update—
15 June 2026, 18:41
Securities Administration—
10 June 2026, 18:12
Substantial Holders—
9 June 2026, 19:02
Substantial Holders—
9 June 2026, 09:03
Securities Administration—
2 June 2026, 09:08
Company Update—
28 May 2026, 18:45
Substantial Holders—
26 May 2026, 08:59
Company UpdateMS
21 May 2026, 14:10
Meetings & Governance—
15 May 2026, 08:46
Company Update—
12 May 2026, 13:09
Securities Administration—
12 May 2026, 13:05
Securities Administration—
4 May 2026, 13:08
Substantial Holders—
1 May 2026, 17:22
Securities Administration—
30 Apr 2026, 08:32
Quarterly ReportsMS
23 Apr 2026, 08:53
Substantial Holders—
20 Apr 2026, 17:30
Meetings & Governance—
16 Apr 2026, 13:51
Substantial Holders—
14 Apr 2026, 17:28
Substantial Holders—
8 Apr 2026, 18:26
Securities Administration—
8 Apr 2026, 18:22
Securities Administration—
2 Apr 2026, 18:19
Substantial Holders—
31 Mar 2026, 20:29
Company Administration—
31 Mar 2026, 20:28
Financial Results—
26 Mar 2026, 18:50
Securities Administration—
26 Mar 2026, 18:40
Securities Administration—
26 Mar 2026, 18:35
Securities AdministrationMS
26 Mar 2026, 09:28
Company Update—
19 Mar 2026, 17:11
Securities Administration—
17 Mar 2026, 18:51
Substantial Holders—
12 Mar 2026, 18:34
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 2 Oct 2026, 15:57 | Resignation and appointment of Company Secretary | Company Administration | — | 12007 | |
| 9 Sept 2026, 08:33 | OSX secures market access to Thailand orthopaedic market | Company Update | — | 11001 | |
| 31 Aug 2026, 19:22 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 6 Aug 2026, 08:45 | OSX strikes orthopaedic deal for 5 Middle East countries | Company Update | MS | 11001 | |
| 3 Aug 2026, 18:25 | Details of Auditor Appointment/Resignation | Other | — | 12018 | |
| 3 Aug 2026, 08:35 | OSX completes first Hainan custom orthopaedic implant | Company Update | — | 11001 | |
| 31 July 2026, 09:01 | Activities Report June 2026 and Appendix 4C | Quarterly Reports | MS | 03026, 19002, 19007 | |
| 23 July 2026, 18:52 | Application for quotation of securities - OSX | Securities Administration | — | 06020 | |
| 14 July 2026, 08:43 | First OSX custom orthopaedic implant delivered to Hainan | Company Update | — | 11001 | |
| 7 July 2026, 08:34 | OSX & Zimmer gain craniofacial market access to Saudi Arabia | Company Update | — | 11001 | |
| 2 July 2026, 08:24 | OSX completes co-development project for neurosurgical guide | Company Update | — | 11001 | |
| 30 June 2026, 08:52 | First patient treated in OSX-PAH jaw reconstruction trial | Company Update | — | 11001 | |
| 29 June 2026, 08:26 | First 2 patients treated in QCH cleft lip clinical trial | Company Update | — | 11001 | |
| 26 June 2026, 08:17 | QCH cleft lip clinical study patient recruitment completed | Company Update | — | 11001 | |
| 24 June 2026, 08:52 | OSX neuro products approved in a major centre in Thailand | Company Update | — | 11001 | |
| 23 June 2026, 09:02 | Cleansing Notice | Securities Administration | — | 06009, 06018 | |
| 23 June 2026, 08:57 | Notification regarding unquoted securities - OSX | Securities Administration | — | 06021 | |
| 23 June 2026, 08:51 | Further Drawdown of T2 of the Redeemable Convertible Notes | Securities Administration | MS | 06009 | |
| 22 June 2026, 08:41 | First OSX custom orthopaedic implant completed in Hong Kong | Company Update | — | 11001 | |
| 17 June 2026, 08:51 | OSX & DKSH Malaysia dental launch First products delivered | Company Update | — | 11001 | |
| 15 June 2026, 18:41 | Notification of cessation of securities - OSX | Securities Administration | — | 06027 | |
| 10 June 2026, 18:12 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 9 June 2026, 19:02 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 9 June 2026, 09:03 | Application for quotation of securities - OSX | Securities Administration | — | 06020 | |
| 2 June 2026, 09:08 | OSX & QCH launch trial for nasoalveolar augment in children | Company Update | — | 11001 | |
| 28 May 2026, 18:45 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 26 May 2026, 08:59 | OSX secures Hainan FDA approval for orthopaedic devices | Company Update | MS | 11001 | |
| 21 May 2026, 14:10 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 15 May 2026, 08:46 | OSX orthopaedic products gain Malaysian market access rights | Company Update | — | 11001 | |
| 12 May 2026, 13:09 | Cleansing Notice | Securities Administration | — | 06018 | |
| 12 May 2026, 13:05 | Application for quotation of securities - OSX | Securities Administration | — | 06020 | |
| 4 May 2026, 13:08 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 1 May 2026, 17:22 | Application for quotation of securities - OSX | Securities Administration | — | 06020 | |
| 30 Apr 2026, 08:32 | Activities Report March 2026 and Appendix 4C | Quarterly Reports | MS | 03026, 19001, 19006 | |
| 23 Apr 2026, 08:53 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 20 Apr 2026, 17:30 | Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004 | |
| 16 Apr 2026, 13:51 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 14 Apr 2026, 17:28 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 Apr 2026, 18:26 | Cleansing Statement | Securities Administration | — | 06018 | |
| 8 Apr 2026, 18:22 | Application for quotation of securities - OSX | Securities Administration | — | 06020 | |
| 2 Apr 2026, 18:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 31 Mar 2026, 20:29 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Mar 2026, 20:28 | Annual Report to Shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 26 Mar 2026, 18:50 | Cleansing Notice | Securities Administration | — | 06018 | |
| 26 Mar 2026, 18:40 | Notification regarding unquoted securities - OSX | Securities Administration | — | 06021 | |
| 26 Mar 2026, 18:35 | Further Drawdown of T2 of the Redeemable Convertible Notes | Securities Administration | MS | 06009 | |
| 26 Mar 2026, 09:28 | OSX receives AUD 520,000 from Majeton | Company Update | — | 11001 | |
| 19 Mar 2026, 17:11 | Expiry of Listed Options | Securities Administration | — | 06009 | |
| 17 Mar 2026, 18:51 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 12 Mar 2026, 18:34 | Clarification - agreement for injectable regen bone filler | Company Update | MS | 11001 |
1–50 of 121
1 / 3